Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shagufa Shaikh
Observed names:
Shagufa A. E. Shaikh,
Shagufa A. Shaikh
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
Observed institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Advanced Centre for Treatment, Research and Education in Cancer
ORCID:
0009-0007-8558-5536
Observed ORCID:
0009-0007-8558-5536
OpenAlex ID:
A5103216565
Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation
2025
·
Nazia Chaudhary
, Dibita Mandal
, et al.
·
Redox Biology
·
13
EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI
2025
·
Nazia Chaudhary
, Bhagya Shree Choudhary
, et al.
·
Cancer Cell International
·
9
Abstract 5663: Chemotherapy-induced galectin-1 derives drug-tolerant persister state associated EMT in triple negative breast cancer with targetable vulnerability to ferroptosis inducers.
2026
·
Shagufa A. Shaikh
, Kedar Sharma
, et al.
·
Cancer Research
·
1
Understanding the Role of Therapy-Induced Secretome in Chemo-resistance and EMT in Triple-Negative Breast Cancer
2024
·
Shagufa A. E. Shaikh
, Kedar Mal Sharma
, et al.
·
Indian Journal of Medical and Paediatric Oncology
Show more works
View as search
Works count:
4
Citation count:
23
H-index:
2
I10-index:
1
Year
Topic
Type